A micrograph showing a high power view of Eosinophils. Calicut Medical College, CC BY-SA 4.0, via Wikimedia Commons
This article was first published by The Times of Israel and is re-posted with permission.
Israeli scientists are harnessing the “destructive” qualities of allergy-causing cells, as part of a bold attempt to pioneer a new immunotherapy for fighting cancer.
A research team from Tel Aviv University has found that eosinophils, white blood cells that induce allergies, significantly reduce the growth of human tumors in vitro, and mouse tumors in the body.
SEE ALSO: Top 5 Recent Advances In Israeli Cancer Research and Treatment
Nine days after mice were injected with eosinophils, the overall size of tumors per mouse averaged half that of mice who weren’t injected.
To read the full article, click here.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Food Of The Future: Nature's Ultimate Recycling Machine
January 16, 2023

Growing High-Protein Mushroom-Based Burgers In Just Four Days
January 09, 2023

Drug Could Bring Immunotherapy To Millions Of Cancer Patients
December 29, 2022

Everlasting Germ Killer, In Paint, Fabric, Plastic And More
December 26, 2022
Facebook comments